Author

Dhananjaya Pal

Levine Cancer InstituteORCID 0000-0001-7675-4819Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1

Frequent Co-Authors

Allison M. PuechliD· 1 shared Bharath Yada· 1 shared Cody C. McHaleiD· 1 shared David FoureauiD· 1 shared Donald L. DurdeniD· 1 shared Erin Crane· 1 shared Hailey L. Dryden· 1 shared Hsih‐Te YangiD· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Allison M. PuechlORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

In silico engineered multitarget-directed ligands for the polypharmaceutical treatment of PTEN loss of function endometrial adenocarcinoma

Ritchie Delara, Vaidehi Mujumdar, Qi Zhang, Hailey L. Dryden, Erin Crane, Jubilee Brown, Wendel Naumann, Allison M. Puechl, David Foureau, Wei Sha, Jessica Legrand, Hsih‐Te Yang, Karl J. Dykema, Bharath Yada, Cody C. McHale, , Donald L. Durden

The paper designs in silico multitarget-directed ligands for treating PTEN loss of function endometrial adenocarcinoma by exploiting synthetic lethality between PTEN LOF and CDK9 inhibition.

bioRxiv · Aug 31, 2026 · PreprintCancer Biology